We set out to assess the feasibility of sFlt-1/PlGF ratio in predicting preeclampsia and adverse pregnancy outcomes using the recently proposed single cut-off values of 38 and preeclampsia screening algorithm developed. The gene discussed is PGF; the disease is preeclampsia.